Toxicity and mainly dysphagia have increased in head and neck cancers as chemoradiation
indications have risen over the last decade, leading to a significant loss of quality of life
for patients. Recently, many retrospective studies and two evidence-based and systematic
reviews on strategies to reduce radiation-induced dysphagia have suggested a trend toward
benefit for a preventive swallowing exercise program.
The main hypothesis of this study is that an early active swallowing therapy can improve the
Quality of Life (QoL) of patients treated by radiotherapy for head and neck cancer.
The study will be a randomized controlled, open-label, multicentric phase III clinical trial
comparing early active swallowing therapy versus non specific swallowing management (usual